FoxWayne Enterprises Acquisition Corp - Ordinary Shares - Class A

NASDAQ:FOXW  
9.97
0.00 (0.00%)
Exchange Changes, Mergers / Acquisitions, Equity Financing / Related

Aerami Therapeutics To Merge With Special Purpose Acquisition Company Foxwayne Enterprises Acquisition Corp. To Become Public Company

Published: 12/07/2021 13:32 GMT
FoxWayne Enterprises Acquisition Corp - Ordinary Shares - Class A (FOXW) - Press Release - Innovative Inhaled Drug Delivery Developer Aerami Therapeutics to Merge With Special Purpose Acquisition Company Foxwayne Enterprises Acquisition Corp.
to Become Public Company.
Foxwayne Enterprises Acquisition Corp - Combined Company's Common Stock is Expected to Continue to Be Listed on Nasdaq Capital Market.
Foxwayne Enterprises Acquisition Corp - Combined Co to Be Named "aerami Therapeutics Holdings, Inc." and Will Be Led by Steve Thornton, CEO of Aerami.
Foxwayne Enterprises Acquisition Corp - Under Deal, Will Be Issuing 25 Million Shares of Common Stock, Which Represents Consideration of About $250 Million.
Foxwayne Enterprises Acquisition Corp - Current Aerami Stockholders Will Convert 100% of Existing Equity Interests Into Common Stock of Combined Co.
Foxwayne Enterprises Acquisition Corp - Current Aerami Stockholders Will Own a Majority of Outstanding Shares of Combined Co Post-closing.